News
Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 second quarter after the market closes on Thursday, ...
Emzotic on MSN11d
10 RARE Dog Breeds You've (probably) Never Heard Of
In Today's video, Em shares facts about her Top 10 Rarest Dog Breeds which you've probably never heard of. Leave a comment with your favorite dog breeds and why you love them! 00:00 - 0:30 Intro 0:30 ...
Bank of America Securities analyst Joshua Shanker maintained a Buy rating on Trupanion today. The company’s shares closed yesterday at $50.86. Elevate Your Investing Strategy: T ...
This award highlights Trupanion's culture of support and investment in team member wellbeingSEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Trupanion (Nasdaq: TRUP), the leading provider of medical ...
StockStory.org on MSN25d
Q1 Rundown: Trupanion (NASDAQ:TRUP) Vs Other Property & Casualty Insurance Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the property & casualty insurance stocks, including Trupanion (NASDAQ:TRUP) and its peers. Property & Casualty (P&C) insurers ...
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended ...
Trupanion (NASDAQ:TRUP – Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Thursday, May 1st. Analysts expect Trupanion to post earnings of ($0 ...
SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first ...
Trupanion, Inc., a leader in pet medical insurance, announced that it will release its financial results for the first quarter of 2025 on May 1, 2025, after the market closes. Following the ...
Trupanion’s underlying Subscription business could deliver strong growth. The company’s speed of claims processing may allow it to meet growing demands for its products. Get Matt Maley’s top ...
Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive. But read why TRUP shares are no longer a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results